Literature DB >> 19431210

Hedgehog and epithelial-mesenchymal transition signaling in normal and malignant epithelial cells of the esophagus.

Noriyuki Isohata1, Kazuhiko Aoyagi, Tomoko Mabuchi, Hiroyuki Daiko, Masahide Fukaya, Hiroyuki Ohta, Kenji Ogawa, Teruhiko Yoshida, Hiroki Sasaki.   

Abstract

It has been established that the Hedgehog (Hh) and epithelial-mesenchymal transition (EMT) signals act on morphogenesis of embryonic and adult tissues. Recently, both signals have been involved in tumor malignancy. However, little is known as to whether Hh and EMT signals act on normal and malignant epithelial cells in the esophagus. By laser microdissection (LMD)-based microarray and reverse transcription polymerase chain reaction in the undifferentiated and differentiated epithelial cells of the esophagus, we compared the expression profiles of Hh and EMT signaling molecules of these cells with those of cancers. Whether and how both signalings act in undifferentiated cells and in cancer cells are investigated by treatment of a Hh-signal inhibitor and/or siRNAs of Hh and EMT transcriptional key regulator genes on a mouse primary culture and on human esophageal squamous cell carcinoma (ESCC) cell lines. Undifferentiated esophageal epithelial cells and most ESCCs coexpressed Hh and EMT signaling genes. Some mesenchymal-related genes were regulated by an EMT regulator SIP1/ZEB2/ZFHX1B, which was a downstream gene of a primary transcriptional transducer GLI1 in Hh signaling. Hh signal block inhibited esophageal keratinocyte differentiation and cancer cell invasion and growth. These findings suggest that the mesenchymal gene expression of undifferentiated cells is maintained or strengthened in cancer cells through Hh signaling. This is a first report showing the presence of crosstalk between Hh and EMT pathways. 2009 UICC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19431210     DOI: 10.1002/ijc.24400

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  Perspectives of gene combinations in phenotype presentation.

Authors:  Shihori Tanabe
Journal:  World J Stem Cells       Date:  2013-07-26       Impact factor: 5.326

2.  MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).

Authors:  Soken Tsuchiya; Takeshi Fujiwara; Fumiaki Sato; Yutaka Shimada; Eiji Tanaka; Yoshiharu Sakai; Kazuharu Shimizu; Gozoh Tsujimoto
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

3.  Novel strategies targeting cancer stem cells through phytochemicals and their analogs.

Authors:  Prasad Dandawate; Subhash Padhye; Aamir Ahmad; Fazlul H Sarkar
Journal:  Drug Deliv Transl Res       Date:  2013-04-01       Impact factor: 4.617

4.  Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous cancers.

Authors:  Gregory N Gan; Justin Eagles; Stephen B Keysar; Guoliang Wang; Magdalena J Glogowska; Cem Altunbas; Ryan T Anderson; Phuong N Le; J Jason Morton; Barbara Frederick; David Raben; Xiao-Jing Wang; Antonio Jimeno
Journal:  Cancer Res       Date:  2014-10-08       Impact factor: 12.701

Review 5.  Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.

Authors:  Anitha K Shenoy; Jianrong Lu
Journal:  Cancer Lett       Date:  2014-10-31       Impact factor: 8.679

Review 6.  Hedgehog signaling and gastrointestinal cancer.

Authors:  Milena Saqui-Salces; Juanita L Merchant
Journal:  Biochim Biophys Acta       Date:  2010-03-19

Review 7.  Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression.

Authors:  Seth B Krantz; Mario A Shields; Surabhi Dangi-Garimella; Hidayatullah G Munshi; David J Bentrem
Journal:  J Surg Res       Date:  2011-10-08       Impact factor: 2.192

8.  Activation of sonic hedgehog signaling pathway is an independent potential prognosis predictor in human hepatocellular carcinoma patients.

Authors:  Li Che; Yan-Hua Yuan; Jun Jia; Jun Ren
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

9.  A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma.

Authors:  Daniel W Bowles; Stephen B Keysar; Justin R Eagles; Guoliang Wang; Magdalena J Glogowska; Jessica D McDermott; Phuong N Le; Dexiang Gao; Charles E Ray; Paul J Rochon; Dennis R Roop; Aik-Choon Tan; Hilary S Serracino; Antonio Jimeno
Journal:  Oral Oncol       Date:  2015-12-15       Impact factor: 5.337

10.  Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer.

Authors:  Stephen B Keysar; Phuong N Le; Ryan T Anderson; J Jason Morton; Daniel W Bowles; Jeramiah J Paylor; Brian W Vogler; Jackie Thorburn; Pamela Fernandez; Magdalena J Glogowska; Sarah M Takimoto; Daniel B Sehrt; Gregory N Gan; Justin R Eagles-Soukup; Hilary Serracino; Fred R Hirsch; M Scott Lucia; Andrew Thorburn; John I Song; Xiao-Jing Wang; Antonio Jimeno
Journal:  Cancer Res       Date:  2013-04-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.